bullish
EBOS Group (EBO NZ): Strong Industry Positioning and Acquisitions to Drive Growth
241 Views05 Apr 2022 21:53
SUMMARY
- Ebos Group Ltd (EBO NZ)'s proposed acquisition of LifeHealthcare has been cleared by Australian Competition Commission, paving the timely closure of the transaction by the end of FY22.
- EBOS has achieved another record result in H1FY22, headlined by double digit revenue and earnings growth, due to continued strong growth trajectory of both healthcare and animal care segments.
- EBOS shares gained 5% since I published bullish insight on December 16. I am still optimistic on the long-term growth prospect of the company.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
- EBOS Group (EBO NZ): Strong Industry Positioning and Acquisitions to Drive Growth05 Apr 2022
- EBOS Group (EBO NZ): Raising Capital to Fund Acquisition; Attractive Bet on Australasian Healthcare16 Dec 2021
x